Back to search

Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanomaa

Data up to Jan 2025

Published1993
Citations60
References49

Total Citations Per Year

Abstract

References (49)

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1991 • 3,493 citations

Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma

1988 • 2,196 citations

Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

1989 • 1,003 citations

Biologic Therapy of Cancer

1992 • 476 citations

Immunological factors which influence response to immunotherapy in malignant melanoma.

1970 • 462 citations

BCG lmmunotherapy of Malignant Melanoma

1974 • 430 citations

Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

1992 • 410 citations

Demonstration of antibodies against human malignant melanoma by immunofluorescence.

1968 • 390 citations

A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).

1983 • 360 citations

Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.

1982 • 242 citations

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

1988 • 239 citations

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

1987 • 224 citations

A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside.

1984 • 222 citations

Complications of BCG Immunotherapy in Patients with Cancer

1973 • 215 citations

Ganglioside GM2 as a human tumor antigen (OFA-I-1).

1983 • 174 citations

Prospectively randomized trial of adjuvant active‐specific immunotherapy for human colorectal cancer

1985 • 164 citations

Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites.

1988 • 153 citations

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer

1985 • 149 citations

Surgical Resection and Adjunctive lmmunotherapy for Selected Patients with Multiple Pulmonary Metastases

1973 • 142 citations

Prolonged Survival for Melanoma Patients With Elevated IgM Antibody to Oncofetal Antigen<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>

1981 • 126 citations

Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma

1989 • 105 citations

Gangliosides and cancer

1989 • 85 citations

Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.

1991 • 76 citations

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases.

1991 • 76 citations

Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide.

1990 • 75 citations

An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.

1989 • 67 citations

A southeastern cancer study group phase I/II trial with vaccinia melanoma oncolysates

1986 • 65 citations

Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.

1991 • 64 citations

Immunogenicity of a polyvalent melanoma antigen vaccine in humans

1988 • 62 citations

Combination tumor‐immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice

1987 • 57 citations

PRELIMINARY RESULTS OF A RANDOMIZED TRIAL OF ADJUVANT IMMUNOTHERAPY IN PATIENTS WITH MALIGNANT MELANOMA WHO HAVE LYMPH NODE METASTASES

1978 • 45 citations

Anti-Idiotype Monoclonal Antibody Carrying the Internal Image of Ganglioside GM3

1990 • 44 citations

Induction of antibodies to a tumor-associated antigen by immunization with a whole melanoma cell vaccine

1989 • 44 citations

Active specific immunotherapy in malignant melanoma

1989 • 41 citations

Active immunotherapy against cancer: present status.

1986 • 39 citations

Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients.

1984 • 38 citations

Active specific immunotherapy with vaccinia colon oncolysate enhances the immunomodulatory and antitumor effects of interleukin-2 and interferon α in a murine hepatic metastasis model

1990 • 30 citations

Induction of CD4+ cytotoxic T cells by sensitization with allogeneic melanomas bearing shared or cross-reactive HLA-A

1992 • 28 citations

Role of Gangliosides in Active Immunotherapy with Melanoma Vaccine

1991 • 28 citations

Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.

1988 • 27 citations

Immunochemical characterization of fetal antigen isolated from spent medium of a human melanoma cell line.

1983 • 27 citations

Modulation of Histamine Type II Receptors on CD8+ T Cells by lnterleukin-2 and Cimetidine

1992 • 24 citations

Production and characterization of a murine/human chimeric anti-idiotype antibody that mimics ganglioside.

1992 • 19 citations

Studies of a Melanoma Tumor-Associated Antigen Detected in the Spent Culture Medium of a Human Melanoma Cell Line by Allogeneic Antibody. I. Purification and Development of a Radioimmunoassay23

1984 • 19 citations

Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A

1992 • 17 citations

Human Tumor Antigens and Specific Tumor Therapy

1990 • 14 citations

Humoral immune response to melanoma-associated membrane antigen and fetal brain antigen demonstrated by indirect membrane immunofluorescence. I

1979 • 13 citations

Rejection of dinitrochlorobenzene-conjugated syngeneic tumor cells by dinitrochlorobenzene-sensitized guinea pigs

1978 • 7 citations

Deleted Work

1955 • 0 citations

Cited By (0)

No citing papers found in database

Polyvalent Melanoma Vaccine Improves Survival of Patients with Metastatic Melanomaa (1993) – Annals of the New York Academy of Sciences | Metascience Observatory Explorer